Corrigendum to “Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophrenia” [Progress in Neuropsychopharmacology & Biological Psychiatry 148 (2026) 111830]

Shuo Wang, Yueru Guo, Boxuan Zhou, Meijuan Li, Qiao Su, Yuying Qiu, Yeqing Dong, Jie Li

Open source

DOI
10.1016/j.pnpbp.2026.111878
Published
2026-08
Container
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pnpbp.2026.111878,
  title = {Corrigendum to “Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophrenia” [Progress in Neuropsychopharmacology \& Biological Psychiatry 148 (2026) 111830]},
  author = {Shuo Wang and Yueru Guo and Boxuan Zhou and Meijuan Li and Qiao Su and Yuying Qiu and Yeqing Dong and Jie Li},
  year = {2026},
  journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  doi = {10.1016/j.pnpbp.2026.111878},
  url = {https://doi.org/10.1016/j.pnpbp.2026.111878}
}

RIS

TY  - JOUR
TI  - Corrigendum to “Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophrenia” [Progress in Neuropsychopharmacology & Biological Psychiatry 148 (2026) 111830]
AU  - Shuo Wang
AU  - Yueru Guo
AU  - Boxuan Zhou
AU  - Meijuan Li
AU  - Qiao Su
AU  - Yuying Qiu
AU  - Yeqing Dong
AU  - Jie Li
PY  - 2026
JO  - Progress in Neuro-Psychopharmacology and Biological Psychiatry
DO  - 10.1016/j.pnpbp.2026.111878
UR  - https://doi.org/10.1016/j.pnpbp.2026.111878
ER  - 

APA

Wang, S., Guo, Y., Zhou, B., Li, M., Su, Q., Qiu, Y., Dong, Y., & Li, J. (2026). Corrigendum to “Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophrenia” [Progress in Neuropsychopharmacology & Biological Psychiatry 148 (2026) 111830]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2026.111878

Source records